RxDoctor Payments Data

Jeffrey Polcer, DO

Anesthesiology · Williamstown, NJNPI 1942274501

Payments from drug & device makers

$2,032in general payments, 2019–2025

Across 97 payments — averaging $20.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$576
  • Abbott$353
  • Boston Scientific$242
  • Collegium Pharmaceutical, Inc.$212
  • Medtronic$174
  • Si-bone, Inc.$102
  • plus $373 from 19 others

What the payments were for

  • Food & beverage$2,032100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,032 in reported general payments places this provider in the 90th percentile of 1,430 anesthesiology providers in New Jersey.

See all anesthesiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$224,833
Medicare patients
184
Services billed
2,478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl25$12,502
OxycontinOxycodone Hcl23$7,691
Oxycodone Hcl262$5,079
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen230$4,819
Buprenorphine Hcl31$2,245
Gabapentin163$2,059
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen88$1,846
Morphine Sulfate ErMorphine Sulfate109$1,823
Lidocaine17$1,303
Tramadol Hcl171$1,174
Pregabalin72$1,097
Tizanidine Hcl105$979
Fentanyl15$877
Tramadol Hcl ErTramadol Hcl13$570
Baclofen40$521

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$212$12,50225 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,430 anesthesiology providers in New Jersey.

Other anesthesiology in Williamstown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →